Claro 14.8 mg Solution is a Health Canada–registered veterinary drug (DIN 02472953) held by Elanco Canada Limited, containing Terbinafine (Terbinafine Hydrochloride). Health Canada lists its status as Marketed (status date 05 Jan 2022). Nexara Health has matched 618 registrations of Terbinafine (Terbinafine Hydrochloride) across 31 other regulated markets.
Health Canada registration
| DIN | 02472953 |
|---|---|
| Brand name | Claro |
| Active ingredient | Terbinafine (Terbinafine Hydrochloride) |
| Strength | 14.8 mg |
| Dosage form | Solution |
| Route | Otic |
| Company | Elanco Canada Limited |
| Status | Marketed — 05 Jan 2022 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Terbinafine (Terbinafine Hydrochloride) registered in other markets
618 registrations of the same molecule in 31 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | APO-Terbinafine | Tx | Tablet 250 mg (as hydrochloride) | GE | PBS | |
| Australia | Lamisil | Np | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | GE | PBS | |
| Australia | Lamisil DermGel | Np | Gel 10 mg per g (1%), 15 g | R1 | PBS | |
| Australia | Pharmacy Action Pharmisil | Gq | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | R1 | PBS | |
| Australia | Terbinafine-DRLA | Rz | Tablet 250 mg (as hydrochloride) | GE | PBS | |
| Australia | Terbinafine-Wgr | Wg | Tablet 250 mg (as hydrochloride) | R1 | PBS | |
| Austria | Amykal 250 mg Tabl. | — | 28St | green box | eEKO (Erstattungskodex) | |
| Austria | Amykal 250 mg Tabl. | — | 14St | green box | eEKO (Erstattungskodex) | |
| Austria | Myconormin 250 mg Tabl. | — | 14St | green box | eEKO (Erstattungskodex) | |
| Austria | Myconormin 250 mg Tabl. | — | 28St | green box | eEKO (Erstattungskodex) | |
| Austria | Terbiderm 250 mg Tabl. | — | 28St | green box | eEKO (Erstattungskodex) | |
| Austria | Terbiderm 250 mg Tabl. | — | 14St | green box | eEKO (Erstattungskodex) | |
| Austria | Terbinafin "Genericon" 250 mg Tabl. | — | 28St | green box | eEKO (Erstattungskodex) | |
| Austria | Terbinafin "Genericon" 250 mg Tabl. | — | 14St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Lamifen | Jamjoom Pharmaceuticals Factory Company, Ksa. | 250 MG | Tablet | POM | NHRA |
| Bahrain | Lamifen | Jamjoom Pharmaceuticals Factory Company, Ksa. | 250 MG | Tablet | POM | NHRA |
| Bahrain | Lamifen | Jamjoom Pharmaceuticals Factory Company, Ksa. | 1 % | Cream | POM | NHRA |
| Bahrain | Lamisil | Novartis Pharma AG, Switzerland. | 125 MG | Tablet | POM | NHRA |
| Bahrain | Lamisil | Novartis Pharma AG, Switzerland. | 250 MG | Tablet | POM | NHRA |
| Bahrain | Lamisil | Karo Healthcare Ab, Sweden. | 1 % | Cream | POM | NHRA |
| Bahrain | Lamisil | Karo Healthcare Ab, Sweden. | 1 % | Cutaneous Spray | POM | NHRA |
| Bahrain | Negafen | Gulf Pharmaceutical Industries (Julphar), Uae. | 1 % | Cream | POM | NHRA |
| Bulgaria | Erbinol | Ворлд Медисине Европа ЕООД | 250 mg tablets | таблетка | По лекарско предписание | BDA |
| Bulgaria | Exoterbyn | Sandoz d.d. | 78,22 mg/ml medicated nail lacquer | лечебен лак за нокти | Без лекарско предписание | BDA |
| Bulgaria | Fungiter | Фортекс Нутрасютикалс ООД | 1 % cream | крем | Без лекарско предписание | BDA |
| Bulgaria | Fungofin | Нобел Фарма Еоод | 1% cream | крем | Без лекарско предписание | BDA |
| Bulgaria | Fungofin | Нобел Фарма Еоод | 1% cutaneous spray, solution | спрей дермален, разтвор | Без лекарско предписание | BDA |
| Bulgaria | Fungofin | Нобел Фарма Еоод | 250 mg tablets | таблетка | По лекарско предписание | BDA |
| Bulgaria | Lamisil | Karo Healthcare AB | 1% cutaneous spray, solution | spray, solution | Без лекарско предписание | BDA |
| Bulgaria | Lamisil | Karo Healthcare AB | 1% cream | крем | Без лекарско предписание | BDA |
| Croatia | Lamisil | Novartis Hrvatska d.o.o. | tbl. 14x250 mg | R | HZZO | |
| Croatia | Terbinax | Belupo d.d. | tbl. 42x250 mg | R | HZZO | |
| Croatia | Terbinax | Belupo d.d. | tbl. 14x250 mg | R | HZZO | |
| Czech Republic | Lamisil | — | 250MG | Tbl Nob | R | SUKL DLP |
| Czech Republic | Lamisil | — | 125MG | Tbl Nob | R | SUKL DLP |
| Czech Republic | Terbinafin Teva | — | 250MG | Tbl Nob | R | SUKL DLP |
| Czech Republic | Terfimed | — | 250MG | Tbl Nob | R | SUKL DLP |
| Denmark | Finigen | Orifarm Generics A/S | 10 mg/g | creme | National | Laegemiddelstyrelsen |
| Denmark | Lamisil | Karo Healthcare AB | 10 mg/g | creme | National | Laegemiddelstyrelsen |
| Denmark | Lamisil | Karo Healthcare AB | 10 mg/g | gel | MRP | Laegemiddelstyrelsen |
| Denmark | Lamisil Once | Karo Healthcare AB | 10 mg/g | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Onychosil | Moberg Pharma AB (publ) | 98 mg/ml | kutanopløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Terbinafin "Actavis" | Actavis Group PTC ehf. | 250 mg | tabletter | MRP | Laegemiddelstyrelsen |
| Denmark | Terbinafin "Epione Medicine" | Epione Medicine ApS | 250 mg | tabletter | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Terbinafin "Hexal" | Hexal A/S | 250 mg | tabletter | MRP | Laegemiddelstyrelsen |
| Finland | Fungis | Sandoz A/S | 1 % | emulsiovoide | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Fungorin | Orion Corporation | 250 mg | tabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Fungorin | Orion Corporation | 1 % | emulsiovoide | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Lamisil | Novartis Finland Oy | 250 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Lamisil | Paranova Oy | 250 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Lamisil | Novartis Finland Oy | 125 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Lamisil | Karo Healthcare AB | 1 % | sumute iholle, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Lamisil | Karo Healthcare AB | 1 % | emulsiovoide | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Greece | CHEMIDERM CREAM 1% W/W BTx1TUBx30 G | Iasis Pharmaceuticals Hellas Βιομηχανια Και Εμπορια Φαρμακευτικων - Χημικων Και Καλλυντικων Προιοντων Α.β.ε.ε., Δ.τ. Iasis Pharma | reimbursed | MoH deltio timwn | ||
| Greece | CHEMIDERM TABLET 250MG/TAB BTx28 (BLISTER 4x7) | Iasis Pharmaceuticals Hellas Βιομηχανια Και Εμπορια Φαρμακευτικων - Χημικων Και Καλλυντικων Προιοντων Α.β.ε.ε., Δ.τ. Iasis Pharma | reimbursed | MoH deltio timwn | ||
| Greece | TERANFIS CREAM 1% W/W BTx1(TUB Alum.x30 g) | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | TERBIN CREAM 1% W/W BTx1TUBx30 G | Boderm Φαρμακευτικη Ανωνυμη Εταιρεια Δ.τ. Boderm A.e. | reimbursed | MoH deltio timwn | ||
| Greece | TERBINAFINE/TARGET CREAM 1% (W/W) TUBx30GR | Ταργκετ Φαρμα Μονοπροσωπη Εταιρεια Περιορισμενης Ευθυνης Δ.τ. Target Pharma Μονοπροσωπη Επε, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | TERBINAFINE/TARGET TABLET 250MG/TAB BTx28 (BLIST 4x7) ή (BLIST 2x14) ή (BLIST 2x14) | Ταργκετ Φαρμα Μονοπροσωπη Εταιρεια Περιορισμενης Ευθυνης Δ.τ. Target Pharma Μονοπροσωπη Επε, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | TERILAM TABLET 250MG/TAB BTx14 (BLIST 1x14) | Medicair Bioscience Laboratories Ανωνυμος Φαρμακευτικη Εταιρεια Δ.τ. Medicair Bioscience Laboratories S.a. | reimbursed | MoH deltio timwn | ||
| Greece | TERILAM TABLET 250MG/TAB BTx28 (BLIST 2x14) | Medicair Bioscience Laboratories Ανωνυμος Φαρμακευτικη Εταιρεια Δ.τ. Medicair Bioscience Laboratories S.a. | reimbursed | MoH deltio timwn | ||
| Hong Kong | Anyzome Cream 1% W/W | Fp Healthcare Limited | Registered | DH Drug Office | ||
| Hong Kong | Bf-Terbinafine Cream 1% W/W | Bright Future Pharmaceutical Co. Limited | Registered | DH Drug Office | ||
| Hong Kong | Dermafin Cream 10mg/g | Yung Shin Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Erbinol Cream 1% W/W | Health Alliance International Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Fumisil Spray 1% | Julius Chen & Company (Hk) Limited | Registered | DH Drug Office | ||
| Hong Kong | Hc Terbinafine Cream 1% | Healthcare Pharmascience Limited | Registered | DH Drug Office | ||
| Hong Kong | Interbi Cream 10mg | Healthcare Pharmascience Limited | Registered | DH Drug Office | ||
| Hong Kong | Jye Mei Cream 1% | Welldone Pharmaceuticals Limited | Registered | DH Drug Office | ||
| Hungary | Myconafine 250 mg Tabletta | PharmaSwiss Česká Republika S.r.o. | 28x buborékcsomagolásban | NEAK PUPHA | ||
| Hungary | Terbinafine-Q Pharma 250 mg Tabletta | Q Pharma Gyógyszerkereskedelmi és Szolgáltató Korlátolt Felelősségű Társaság | 28x buborékcsomagolásban (pvc-pvdc/al) | NEAK PUPHA | ||
| Hungary | Terbiner 250 mg Tabletta | Mediner Gyógyszerkereskedelmi, Marketing és Szolgáltató Korlátolt Felelősségű Társaság | 14x buborékcsomagolásban (pvc/pvdc//al) | NEAK PUPHA | ||
| Hungary | Terbiner 250 mg Tabletta | Mediner Gyógyszerkereskedelmi, Marketing és Szolgáltató Korlátolt Felelősségű Társaság | 28x buborékcsomagolásban (pvc/pvdc//al) | NEAK PUPHA | ||
| Hungary | Terbisil 250 mg Tabletta | Richter Gedeon Vegyészeti Gyár Nyilvánosan Működő Részvénytársaság | 28x buborékcsomagolásban | NEAK PUPHA | ||
| Hungary | Terbisil Kid 125 mg Tabletta | Richter Gedeon Vegyészeti Gyár Nyilvánosan Működő Részvénytársaság | 14x buborékcsomagolásban pvc//al | NEAK PUPHA | ||
| Iceland | Lamisil | Karo Healthcare AB | 10 mg/g | krem | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Lamisil | Karo Healthcare AB | 10 mg/g | krem | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Lamisil Once | Karo Healthcare AB | 1 % | húðlausn | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Terbinafin Actavis | Actavis Group PTC ehf | 250 mg | töflur | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Terbinafin Actavis | Actavis Group PTC ehf | 250 mg | töflur | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Terbinafin Medical Valley | Medical Valley Invest AB | 250 mg | töflur | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Terbinafin Medical Valley | Medical Valley Invest AB | 250 mg | töflur | 2 | Lyfjastofnun lyfjaverdskra |
| Ireland | Fungasil 250 mg tablets | Clonmel Healthcare Ltd | Tablet | Marketed | HPRA | |
| Ireland | Lamisil 1% w/w cream | PCO Manufacturing Ltd. | Cream | Unknown | HPRA | |
| Ireland | Lamisil 1% w/w cream | IMED Healthcare Ltd., | Cream | Unknown | HPRA | |
| Ireland | Lamisil 1% w/w Cream | Karo Pharma AB | Cream | Marketed | HPRA | |
| Ireland | Lamisil 250 mg tablets | IMED Healthcare Ltd., | Tablet | Unknown | HPRA | |
| Ireland | Lamisil 250 mg tablets | Novartis Ireland Limited | Tablet | Not marketed | HPRA | |
| Ireland | Lamisil 250 mg tablets | PCO Manufacturing Ltd. | Tablet | Unknown | HPRA | |
| Ireland | Lamisil AT Cream | Karo Pharma AB | Cream | Marketed | HPRA | |
| MA | Lamisil | — | 250 MG | Comprime Secable | P | CNOPS liste des medicaments |
| MA | Lamisil | — | 1 % | Creme | P | CNOPS liste des medicaments |
| MA | Lamisil | — | 1 % | Creme | P | CNOPS liste des medicaments |
| MA | Lamisil | — | 250 MG | Comprime Secable | P | CNOPS liste des medicaments |
| MA | Lifongid | — | 250 MG | Comprime | G | CNOPS liste des medicaments |
| MA | Lifongid | — | 1 % | Solution Pour Application Locale | G | CNOPS liste des medicaments |
| MA | Lifongid | — | 250 MG | Comprime | G | CNOPS liste des medicaments |
| MA | Lifongid | — | 1 % | Creme | G | CNOPS liste des medicaments |
| Malta | LAMISIL 1% cream | NeoFarma Pharmaceuticals Limited | Cream | Authorised | Medicines Authority | |
| Malta | Terbinafine Aurobindo 125mg Tablets | Aurobindo Pharma (Malta) Limited | Tablet | Authorised | Medicines Authority | |
| Malta | Terbinafine Aurobindo 250mg Tablets | Aurobindo Pharma (Malta) Limited | Tablet | Authorised | Medicines Authority | |
| Netherlands | Lamisil DermGel 1%, gel | Karo Healthcare AB | Gel | Uitsluitend recept | EU national register | |
| Norway | Lamisil DermGel gel 1 % | Karo Healthcare AB | 15 | Gel | Aktiv oppføring | FEST (DMP) |
| Norway | Lamisil hudspray, oppl 10 mg/ml | Karo Healthcare AB | 15 | Hudspray, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Lamisil krem 10 mg/g | Karo Healthcare AB | 30 | Krem | Aktiv oppføring | FEST (DMP) |
| Norway | Lamisil krem 10 mg/g | Karo Healthcare AB | 15 | Krem | Aktiv oppføring | FEST (DMP) |
| Norway | Lamisil liniment, oppl 1 % w/w | Karo Healthcare AB | 4 | Liniment, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Terbinafin 1a pharma tab 250 mg | 1 A Pharma | 42 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Terbinafin Hexal tab 250 mg | Hexal A/S | 28 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Terbinafin Hexal tab 250 mg | Hexal A/S | 98 | Tablett | Aktiv oppføring | FEST (DMP) |
| Poland | Erfin | Polfarmex S.A. | 250 mg | Tabletki | Bezterminowe | URPL RPL |
| Poland | Krem przeciwgrzybiczny do stóp | Scholl’s Wellness Company B.V. | 10 mg/g | Krem | Bezterminowe | URPL RPL |
| Poland | Lamisil | Novartis Poland Sp. z o.o. | 250 mg | Tabletki | 2024-12-10 | URPL RPL |
| Poland | Lamisil | Novartis Poland Sp. z o.o. | 125 mg | Tabletki | 2024-12-10 | URPL RPL |
| Poland | Lamisilatt | Medezin Sp. z o.o. | 10 mg/g | Krem | 2031-08-12 | URPL RPL |
| Poland | Lamisilatt | Delfarma Sp. z o.o. | 10 mg/g | Krem | 2030-01-18 | URPL RPL |
| Poland | Lamisilatt | Karo Healthcare AB | 10 mg/g | Krem | Bezterminowe | URPL RPL |
| Poland | Myconafine | Aristo Pharma Sp. z o.o. | 250 mg | Tabletki | Bezterminowe | URPL RPL |
| Romania | EXOTERFYN 78,22 mg/ml | — | 78,22mg/ml | Lac De Unghii Medicamentos | OTC | ANMDMR nomenclator |
| Romania | TAFICEN 10 mg/g | — | 10mg/g | Crema | OTC | ANMDMR nomenclator |
See every manufacturer of Terbinafine (Terbinafine Hydrochloride) worldwide →
Regulator price references for Terbinafine (Terbinafine Hydrochloride)
Published list or reimbursement prices for Terbinafine (Terbinafine Hydrochloride) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Terbinafine-DRLA | Tablet 250 mg (as hydrochloride) | 11.88 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Terbinafine-Wgr | Tablet 250 mg (as hydrochloride) | 11.88 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Terbinafine-Wgr | Tablet 250 mg (as hydrochloride) | 11.88 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Lamisil | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | 12.51 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Trust Terbinafine Cream | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | 12.51 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Lamisil DermGel | Gel 10 mg per g (1%), 15 g | 13.69 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Amykal 250 mg Tabl. | 250mg | 14St | 12.15 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Terbiderm 250 mg Tabl. | 250mg | 14St | 12.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Terbinafin "Genericon" 250 mg Tabl. | 250mg | 14St | 12.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Myconormin 250 mg Tabl. | 250mg | 14St | 12.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Amykal 250 mg Tabl. | 250mg | 28St | 22.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Terbinafin "Genericon" 250 mg Tabl. | 250mg | 28St | 22.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Terbiderm 250 mg Tabl. | 250mg | 28St | 22.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Myconormin 250 mg Tabl. | 250mg | 28St | 23.00 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Negafen | 1pct | 15G | 1.41 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Terfina | 1pct | 15G | 1.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamifen | 1pct | 15G | 1.92 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamisil | 1pct | 15G | 2.65 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Turbosil | 1pct | 1 X 30ML | 3.05 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamisil | 125mg | 14 | 4.17 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamisil | 1pct | 30ML | 4.56 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamifen | 250mg | 7 | 6.46 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamisil | 250mg | 14 | 6.77 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Negafen | 250mg | 14 | 9.50 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lamifen | 250mg | 14 | 11.63 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | TERBIN CREAM 1% W/W BTx1TUBx30 G | 1pct+30000mg | 3.60 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TERANFIS CREAM 1% W/W BTx1(TUB Alum.x30 g) | 1pct+30000mg | 3.60 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CHEMIDERM CREAM 1% W/W BTx1TUBx30 G | 1pct+30000mg | 3.60 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TERBINAFINE/TARGET CREAM 1% (W/W) TUBx30GR | 1pct | 3.60 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TERILAM TABLET 250MG/TAB BTx14 (BLIST 1x14) | 250mg | 4.08 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TERILAM TABLET 250MG/TAB BTx28 (BLIST 2x14) | 250mg | 8.15 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TERBINAFINE/TARGET TABLET 250MG/TAB BTx28 (BLIST 4x7) ή (BLIST 2x14) ή (BLIST 2x14) | 250mg | 8.15 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CHEMIDERM TABLET 250MG/TAB BTx28 (BLISTER 4x7) | 250mg | 8.15 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ZAKOFIN TABLET 250MG/TAB BTx28 (BLIST 4x7) (PVC/ALUM.FOIL) (PVC/ALUM.FOIL) | 250mg | 8.15 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Terbiner 250 mg Tabletta | 250mg | 14x buborékcsomagolásban (pvc/pvdc//al) | 1,984.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Terbisil Kid 125 mg Tabletta | 125mg | 14x buborékcsomagolásban pvc//al | 3,156.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Terbinafine-Q Pharma 250 mg Tabletta | 250mg | 28x buborékcsomagolásban (pvc-pvdc/al) | 3,299.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Myconafine 250 mg Tabletta | 250mg | 28x buborékcsomagolásban | 3,300.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Terbiner 250 mg Tabletta | 250mg | 28x buborékcsomagolásban (pvc/pvdc//al) | 3,650.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Terbisil 250 mg Tabletta | 250mg | 28x buborékcsomagolásban | 3,797.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Terbinafin Medical Valley | 250mg | þpakki | 1,860.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Terbinafin Actavis | 250mg | þpakki | 3,147.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Terbinafin Medical Valley | 250mg | þpakki | 5,634.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Terbinafin Actavis | 250mg | þpakki | 7,640.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| MA | Onifine 1% | 1pct | 1 TUBE 15 G | 34.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lifongid | 1pct | 1 TUBE 15 G | 40.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Teguma | 1pct | 1 TUBE 15 G | 45.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lamisil | 1pct | 1 TUBE 15 G | 52.80 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Onifine 1% | 1pct | 1 FLACON 30 ML | 56.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Onifine 1% | 1pct | 1 TUBE 30 G | 58.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lifongid | 1pct | 1 FLACON 30 ML | 59.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lifongid | 1pct | 1 TUBE 30 G | 59.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terfine 250 mg Promopharm | 250mg | 1 BOITE 7 COMPRIME | 62.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Teguma | 250mg | 1 BOITE 7 COMPRIME | 65.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Teguma | 1pct | 1 FLACON 30 ML | 70.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Teguma | 1pct | 1 TUBE 30 G | 70.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lifongid 250mg | 250mg | 1 BOITE 7 COMPRIME | 75.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terbinafine Gt | 250mg | 1 BOITE 7 COMPRIME | 75.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terix 250 mg | 250mg | 1 BOITE 7 COMPRIME | 82.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terfine 250 mg Promopharm | 250mg | 1 BOITE 14 COMPRIME | 111.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Teguma | 250mg | 1 BOITE 14 COMPRIME | 120.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Onifine | 250mg | 1 BOITE 14 COMPRIME | 132.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lifongid 250mg | 250mg | 1 BOITE 14 COMPRIME | 139.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terbinafine Gt | 250mg | 1 BOITE 14 COMPRIME | 142.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terix | 250mg | 1 BOITE 14 COMPRIME | 157.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terfine 250 mg Promopharm | 250mg | 1 BOITE 28 COMPRIME | 199.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Teguma | 250mg | 1 BOITE 28 COMPRIME | 199.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Onifine | 250mg | 1 BOITE 28 COMPRIME | 237.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lifongid | 250mg | 1 BOITE 28 COMPRIME | 249.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terbinafine Gt | 250mg | 1 BOITE 28 COMPRIME | 269.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lamisil | 250mg | 1 BOITE 14 COMPRIME SECABLE | 288.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Terix | 250mg | 1 BOITE 28 COMPRIME | 296.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lamisil | 250mg | 1 BOITE 28 COMPRIME SECABLE | 493.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| United Arab Emirates | Negafen | 10mg/1000mg | 15 g Aluminum Collapsible Tube | 20.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Terfina 1% | 10mg/1000mg | 15g Collapsible Tube | 22.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lamisil ® 1% | 1pct | 15 g Tube | 23.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Negafen | 10mg/1000mg | 30 g Aluminum Collapsible Tube | 32.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Medisil 1% | 10mg/1000mg | 30g Collapsible Tube | 36.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Glenisil ® | 10mg/1000mg | 30g Collapsible Tube | 36.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lamisil ® 1% | 1pct | 30ml Spray Bottle | 43.50 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Claro (DIN 02472953) marketed in Canada?
Yes. Health Canada lists DIN 02472953 as Marketed as of 05 Jan 2022.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Terbinafine (Terbinafine Hydrochloride) registered outside Canada?
Yes — Nexara Health has matched 618 registrations in 31 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02472953, status date 2022-01-05; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02472953, status date 2022-01-05; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS.
Elanco Canada Limited — company profileWho else makes Terbinafine (Terbinafine Hydrochloride)All Canadian Terbinafine (Terbinafine Hydrochloride) products
Health Canada Drug Product Database (DPD), DIN 02472953, status date 2022-01-05; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NEAK PUPHA, NHRA, PBS, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.